Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
03 12 2019
Historique:
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 8 1 2021
Statut: ppublish

Résumé

Background Circulating proteins are exposed to vascular endothelial layer and influence their functions. Among them, adipsin is a member of the trypsin family of peptidases and is mainly secreted from adipocytes, monocytes, and macrophages, catalyzing the rate-limiting step of the alternative complement pathway. However, its pathophysiological role in cardiovascular disease remains to be elucidated. Here, we examined whether serum adipsin levels have a prognostic impact in patients with coronary artery disease. Methods and Results In 370 consecutive patients undergoing diagnostic coronary angiography, we performed a cytokine array analysis for screening serum levels of 50 cytokines/chemokines and growth factors. Among them, classification and regression analysis identified adipsin as the best biomarker for prediction of their long-term prognosis (median 71 months; interquartile range, 55-81 months). Kaplan-Meier curve showed that higher adipsin levels (≥400 ng/mL) were significantly associated with all-cause death (hazard ratio [HR], 4.2; 95% CI, 1.7-10.6 [

Identifiants

pubmed: 31752640
doi: 10.1161/JAHA.119.013716
pmc: PMC6912964
doi:

Substances chimiques

Biomarkers 0
CFD protein, human EC 3.4.21.46
Complement Factor D EC 3.4.21.46

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e013716

Références

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):493-8
pubmed: 10073948
Circulation. 2012 Jan 3;125(1):e2-e220
pubmed: 22179539
Ann Neurol. 2012 Apr;71(4):478-86
pubmed: 22522440
J Am Coll Cardiol. 2016 Feb 16;67(6):712-723
pubmed: 26868696
Am Heart J. 2004 Jul;148(1 Suppl):S19-26
pubmed: 15211329
Am J Cardiol. 2011 Oct 1;108(7):1045-51
pubmed: 21784384
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1513-1523
pubmed: 28473439
BMJ. 2012 Apr 24;344:e2697
pubmed: 22531797
Clin Endocrinol (Oxf). 2016 Dec;85(6):910-917
pubmed: 27434652
Eur Heart J. 2014 Jul 14;35(27):1776-8
pubmed: 24658770
Nat Rev Cancer. 2012 Jun 22;12(7):465-77
pubmed: 22722403
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Acta Neurol Belg. 2017 Dec;117(4):879-883
pubmed: 28550440
J Exp Med. 2011 Jan 17;208(1):53-66
pubmed: 21173104
Clin Chem. 2013 Sep;59(9):1330-7
pubmed: 23669527
Lancet. 2011 Jan 1;377(9759):31-41
pubmed: 21144578
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):636-46
pubmed: 26916734
Cytokine. 2018 Nov;111:20-27
pubmed: 30098476
Science. 1989 Jun 23;244(4911):1483-7
pubmed: 2734615
Int J Cardiol. 2006 Mar 22;108(1):20-5
pubmed: 16516694
Circ Res. 2017 Apr 14;120(8):1246-1262
pubmed: 28289017
Circ Res. 2015 Mar 27;116(7):1098-100
pubmed: 25814676
Int J Obes (Lond). 2010 Jan;34(1):118-26
pubmed: 19823188
Circ Res. 2014 Sep 26;115(8):738-50
pubmed: 25149188
J Am Coll Cardiol. 2009 Oct 27;54(18):1695-702
pubmed: 19850209
J Am Coll Cardiol. 2006 Jan 3;47(1):85-90
pubmed: 16386669
Nat Med. 2009 Jun;15(6):649-56
pubmed: 19430489
Mult Scler Int. 2015;2015:371734
pubmed: 26634156
JAMA. 2006 Jan 4;295(1):74-80
pubmed: 16391219
Cancer Cell. 2016 Dec 12;30(6):829-830
pubmed: 27960080
Lancet Oncol. 2010 Jul;11(7):627-36
pubmed: 20542468
Circulation. 2004 Apr 27;109(16):1955-9
pubmed: 15051634
JAMA. 2005 Oct 12;294(14):1799-809
pubmed: 16219884
Cell. 2014 Jul 3;158(1):41-53
pubmed: 24995977
J Biol Chem. 1992 May 5;267(13):9210-3
pubmed: 1374388
J Am Coll Cardiol. 2016 Jul 19;68(3):265-271
pubmed: 27417004
Nat Rev Immunol. 2008 Oct;8(10):776-87
pubmed: 18802444
Science. 1993 Jan 1;259(5091):87-91
pubmed: 7678183
PLoS One. 2016 Sep 09;11(9):e0162228
pubmed: 27611793
Clin Biochem. 2002 Jul;35(5):347-53
pubmed: 12270763
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Science. 1987 Jul 24;237(4813):405-8
pubmed: 3299706
J Am Heart Assoc. 2019 Dec 3;8(23):e013716
pubmed: 31752640
Tohoku J Exp Med. 2006 Jul;209(3):197-206
pubmed: 16778366
N Engl J Med. 2004 Feb 12;350(7):655-63
pubmed: 14960742
Circulation. 2008 Jun 17;117(24):3088-98
pubmed: 18541741
J Am Coll Cardiol. 2013 Sep 3;62(10):881-6
pubmed: 23810869
Hypertension. 2016 May;67(5):878-89
pubmed: 26975711
Circ Res. 2017 Jan 6;120(1):8-10
pubmed: 28057780
Dokl Biochem Biophys. 2017 Jul;475(1):271-276
pubmed: 28864895
Eur Heart J. 2014 Dec 1;35(45):3180-93
pubmed: 25354517
Heart. 2007 Sep;93(9):1087-92
pubmed: 17309906
Circ J. 2013;77(12):2851-9
pubmed: 24240435
Circ J. 2012;76(5):1136-44
pubmed: 22343268
Nat Med. 2001 Aug;7(8):941-6
pubmed: 11479627
Circ Res. 2015 Aug 28;117(6):525-35
pubmed: 26224795
Circ J. 2015;79(9):2009-16
pubmed: 26118344
Circ Res. 2016 Jan 22;118(2):352-66
pubmed: 26838319
JAMA. 1998 Apr 1;279(13):1000-4
pubmed: 9533498
Circulation. 2006 Aug 15;114(7):623-9
pubmed: 16894037
Heart. 2008 Apr;94(4):429-33
pubmed: 17646194
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70
pubmed: 12756299
N Engl J Med. 2006 Dec 21;355(25):2631-9
pubmed: 17182988

Auteurs

Tomohiro Ohtsuki (T)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Kimio Satoh (K)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Toru Shimizu (T)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Shohei Ikeda (S)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Nobuhiro Kikuchi (N)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Taijyu Satoh (T)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Ryo Kurosawa (R)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Masamichi Nogi (M)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Shinichiro Sunamura (S)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Nobuhiro Yaoita (N)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Junichi Omura (J)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Tatsuo Aoki (T)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Shunsuke Tatebe (S)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Koichiro Sugimura (K)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Jun Takahashi (J)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Satoshi Miyata (S)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Hiroaki Shimokawa (H)

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH